1. Treating Nonalcoholic Fatty Liver Disease From the Outside In? Flynn CR (2019) Cell Mol Gastroenterol Hepatol 7(3): 682-683
    › Primary publication · 30677403 (PubMed) · PMC6477184 (PubMed Central)
  2. Systemic bile acids induce insulin resistance in a TGR5-independent manner. Syring KE, Cyphert TJ, Beck TC, Flynn CR, Mignemi NA, McGuinness OP (2019) Am J Physiol Endocrinol Metab 316(5): E782-E793
    › Primary publication · 30779633 (PubMed) · PMC6732652 (PubMed Central)
  3. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery. Albaugh VL, Banan B, Antoun J, Xiong Y, Guo Y, Ping J, Alikhan M, Clements BA, Abumrad NN, Flynn CR (2019) Gastroenterology 156(4): 1041-1051.e4
    › Primary publication · 30445014 (PubMed) · PMC6409186 (PubMed Central)
  4. Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling. Samovski D, Dhule P, Pietka T, Jacome-Sosa M, Penrose E, Son NH, Flynn CR, Shoghi KI, Hyrc KL, Goldberg IJ, Gamazon ER, Abumrad NA (2018) Diabetes 67(7): 1272-1284
    › Primary publication · 29748289 (PubMed) · PMC6014550 (PubMed Central)
  5. In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate. Fuller JC, Pitchford LM, Morrison RD, Daniels JS, Flynn CR, Abumrad NN, Oates JA, Boutaud O, Rathmacher JA (2018) Food Chem Toxicol : 541-548
    › Primary publication · 30253245 (PubMed) · PMC6220894 (PubMed Central)
  6. CD36 Modulates Fasting and Preabsorptive Hormone and Bile Acid Levels. Shibao CA, Celedonio JE, Tamboli R, Sidani R, Love-Gregory L, Pietka T, Xiong Y, Wei Y, Abumrad NN, Abumrad NA, Flynn CR (2018) J Clin Endocrinol Metab 103(5): 1856-1866
    › Primary publication · 29546316 (PubMed) · PMC6446573 (PubMed Central)
  7. Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward. Reddy IA, Smith NK, Erreger K, Ghose D, Saunders C, Foster DJ, Turner B, Poe A, Albaugh VL, McGuinness O, Hackett TA, Grueter BA, Abumrad NN, Flynn CR, Galli A (2018) PLoS Biol 16(7): e2006682
    › Primary publication · 30048457 (PubMed) · PMC6061973 (PubMed Central)
  8. Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension. Dikalova AE, Itani HA, Nazarewicz RR, McMaster WG, Flynn CR, Uzhachenko R, Fessel JP, Gamboa JL, Harrison DG, Dikalov SI (2017) Circ Res 121(5): 564-574
    › Primary publication · 28684630 (PubMed) · PMC5562527 (PubMed Central)
  9. Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Wattacheril J, Rose KL, Hill S, Lanciault C, Murray CR, Washington K, Williams B, English W, Spann M, Clements R, Abumrad N, Flynn CR (2017) Hepatol Res 47(13): 1469-1483
    › Primary publication · 28258704 (PubMed) · PMC5583035 (PubMed Central)
  10. Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation. Cheung-Flynn J, Song J, Voskresensky I, Wise ES, Liu Y, Xiong Y, Eagle SS, Brophy CM, Flynn CR (2017) Sci Rep 7(1): 14179
    › Primary publication · 29079734 (PubMed) · PMC5660200 (PubMed Central)